Bicara Therapeutics Inc. - BCAX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 13, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP Ltd. | 4.8% | 3,171,015 | View |
| May 15, 2026 | SCHEDULE 13G/A | Vestal Point Capital, LP | 8.3% | 5,425,000 | View |
| May 15, 2026 | SCHEDULE 13G/A | Ryan Wilder | 8.3% | 5,425,000 | View |
| May 15, 2026 | SCHEDULE 13G | JANUS HENDERSON GROUP PLC | 5.1% | 3,339,218 | View |
| May 15, 2026 | SCHEDULE 13G/A | Deep Track Capital, LP | 6.21% | 4,062,500 | View |
| May 15, 2026 | SCHEDULE 13G/A | Deep Track Biotechnology Master Fund, Ltd. | 6.21% | 4,062,500 | View |
| May 15, 2026 | SCHEDULE 13G/A | David Kroin | 6.21% | 4,062,500 | View |
| May 08, 2026 | SCHEDULE 13G/A | Red Tree GP, LLC | 4.8% | 3,170,509 | View |
| May 08, 2026 | SCHEDULE 13G/A | Red Tree Venture Fund, L.P. | 4.8% | 3,170,509 | View |
| May 08, 2026 | SCHEDULE 13G/A | Heath Lukatch | 4.8% | 3,170,509 | View |
| May 06, 2026 | SCHEDULE 13G/A | FMR LLC | 3.2% | 2,100,929 | View |
| May 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 3.2% | 2,100,929 | View |
| Apr 08, 2026 | SCHEDULE 13G/A | T. Rowe Price Investment Management, Inc. | 10.1% | 6,605,780 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.